Argus Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) StockMarket Beat·11 hours agoMRK+3.84%
HHS said to be eyeing two new FDA deputy commissioners for technology and drugsbusinessinsider·6 hours agoTWST+7.54%TEM+3.87%
12:38 ETRegeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman Sobol Shapiro LLPprnewswire·1 day ago, 11:40 AMREGN+0.61%
BioNTech (BNTX) Is Up 27.3% After Novel Pumitamig Combo Data in Lung Cancer – Has The Bull Case Changed?Simplywall·1 day ago, 08:25 AMBNTX+1.09%
ImmuneOnco says first PAH patient dosed in Phase Ib/IIa trial of IMC-003PUBT·13 hours ago01541+4.25%MRK+3.84%
Key facts: Merck (MRK) up on vaccine; policy may hit M-M-R II, ProQuadTradingView·1 day ago, 02:14 AMMRK+3.84%
Court Rejects Merck’s Challenge to Medicare Drug Price Negotiation Programbenzinga_article·11 hours agoMRK+3.84%
Merck & Co., Inc. $MRK Shares Purchased by Russell Investments Group Ltd.Market Beat·1 day ago, 04:05 AMMRK+3.84%
Vega Investment Solutions Acquires New Shares in Regeneron Pharmaceuticals, Inc. $REGNMarket Beat·14 hours agoREGN+0.61%
Osmosis Investment Management UK Ltd Acquires Shares of 21,075 Vertex Pharmaceuticals Incorporated $VRTXMarket Beat·1 day ago, 05:24 AMVRTX+0.96%BLK+0.34%
Abbisko turns to IFRS net loss of RMB 193.47 million in FY26 H1; revenue drops 84% to RMB 97.27 millionPUBT·1 day ago, 08:24 AM02256+0.05%MRK+3.84%
